PEABODY, Mass., Feb. 13 /PRNewswire-FirstCall/ -- PHC, Inc., d.b.a. Pioneer Behavioral Health (BULLETIN BOARD: PIHC) , a leading provider of inpatient and outpatient behavioral health services, today announced its fiscal 2007 second quarter financial results, for the period ended December 31, 2006.
Key Financial Indicators
(all numbers in thousands, except per-share amounts)
Q2 2007 Q2 2006 Increase % Change
(decrease)
Consolidated revenues $9,952 $8,702 $1,250 14.4%
Patient care revenues $7,947 $6,465 $1,481 22.9%
Pharmaceutical study
revenues $874 $1,084 $(210) (19.4%)
Contract support service
revenues $1,132 $1,153 $(21) (1.8)%
Income from operations $605 $549 $56 10.2%
Pretax Income $423 $411 $12 2.9%
Net Income $261 $347 $(86) (24.8%)
Earnings per share - Basic $0.01 $0.02 $(0.01) (50.0%)
Diluted $0.01 $0.02 $(0.01) (50.0%)
Financial Results
Total net revenue from operations increased 14.4 percent to $10.0 million for the three months ended December 31, 2006 from $8.7 million for the three months ended December 31, 2005. Net patient care revenue increased 22.9 percent to $7.9 million for the quarter from $6.5 million for the same quarter last year. This increase in revenue is due primarily to the addition of the 20 adjudicated juvenile beds at Detroit Behavioral Institute, which contributed to a 12.2 percent increase in patient days for the three months compared to the same period last year. Revenue from pharmaceutical studies decreased 19.4 percent to $874,000 for the quarter compared to $1.1 million for the three months ended December 31, 2005 due to the cyclical nature of the pharmaceutical research business, where the size and number of clinical trial starts and stops change daily. Contract support services revenue provided by Wellplace decreased 1.8 percent to $1.1 million for the quarter from $1.2 million for the same quarter last year.
"The investments and developments we have made in our Patient Care segment during fiscal 2006 have begun to yield the significant contributions to our revenues that we anticipated," commented Bruce A. Shear, President and Chief Executive Officer of Pioneer Behavioral Health. "The 22.9 percent increase in patient care revenue resulted from the addition of the 20 adjudicated juvenile beds at Detroit Behavioral Institute, which enabled a 12.2 percent increase in patient days for the quarter. This also represented an acceleration of 560 basis points in patient care revenue growth compared to the first fiscal quarter of 2007. We continue to view bed count as a key metric of our financial health, and even as we currently have the highest bed count totals and patient days levels in our Company's history, we stand poised to further accelerate this growth next year following the planned expansion in Las Vegas."
Total operating expenses for the quarter increased 15.0 percent to $9.3 million from $8.2 million during the second quarter of last year. Included in this increase was a 28.9 percent increase in patient care expenses. Through January 2007, the Company has invested approximately $500,000 in the Las Vegas market, including $400,000 in the Seven Hills project and $100,000 in the start-up of our 10-year, $80 million agreement with Health Plan of Nevada's Behavioral Healthcare Options network agreement. The increase in operating expenses also included a $100,100, or 17.1 percent, increase in other expenses and 13% higher administrative costs to $369,000, compared to last year's period, which was primarily due to various set-up and other infrastructure costs necessitated by the expansion at Detroit Behavioral Institute and our new software installation.
Income from operations for the quarter was $605,000, up 10.2 percent from the $549,000 reported for the same period last year. Interest expense of $212,000 was 21 percent higher, due in large part to an earn-out related $80,000 increase in interest expense at Pivotal Research Centers. Net income for the three months was $261,000, or $0.01 per fully diluted share (based on 19.4 million fully diluted shares) compared to net income of $347,000, or $0.02 per fully diluted share (based on 19.3 million shares) for the second quarter last year.
This year's second fiscal quarter was the second consecutive quarter in which the Company recorded an income tax provision assuming an estimated 39 percent corporate tax rate, while in the prior-year quarter, the Company recorded a 16 percent tax rate for the income tax provision. Had the Company incurred the same 39 percent tax rate in the year-ago period, net income for the second quarter of fiscal 2006 would have been $255,000, which is marginally lower than in this year's second quarter.
The Company's provision for doubtful accounts in the quarter decreased to $347,000 from $476,000 in the year-ago same period. The percentage of bad debt expense to net patient care revenue for the quarter ended December 31, 2006 was 4.4 percent compared to 7.4 percent last year.
For the six-month period ended December 31, 2006, total net revenue from operations increased 13.4 percent to $20.0 million compared to $17.6 million for the first six months last year. Net patient care revenue increased 20.1 percent to $15.8 million for the six months from $13.2 million for the same period last year. Revenue from pharmaceutical studies decreased 19.5 percent to $1.9 million for the six-month period from $2.4 million for the same period last year. Contract support services revenue provided by Wellplace increased 9.0 percent to $2.3 million for the six months from $2.1 million for the six months ended December 31, 2005.
Patient care expenses in treatment centers increased 25.1 percent to $8.2 million for the six months from $6.6 million last year. Patient care expenses related to pharmaceutical or research division decreased 15.4 percent to $908,000 for the six months from $1.1 million last year. Contract support services expenses increased 28.8 percent to $1.5 million for the six months from $1.2 million last year. Administrative expenses increased 15.5 percent to $6.2 million for the six months from $5.4 million for the six months ended December 31, 2005.
Income from operations was $1.2 million for the first six months of both fiscal 2007 and 2006. Net income was $544,000, or $0.03 per basic and fully diluted share (based on 19.3 million shares), down 25.5 percent compared to the $731,000, or $0.04 per basic and fully diluted share (based on 19.3 million shares) last year. Our blended average tax rate for the six-month period this year was 39% as compared to 18% in last year's same period. Adjusting last year's six-month result for this year's comparable tax rate, our net income would have been $544,000, largely unchanged compared to this year's same period.
Mr. Shear continued, "Our presence in the Las Vegas metropolitan area, which we expect to be a key driver of our future growth, continues to expand. The opening of the Seven Hills Behavioral Institute will be complemented by the strong and growing presence of our Harmony Healthcare subsidiary, which serves 21 separate properties in that area. We are excited to announce that we have begun work on the 10-year, $80 million contract with Health Plan of Nevada, as announced in December, under which Harmony will continue to provide inpatient hospitalization services, outpatient services, individual and group therapy, medication management, psychological testing, as well as crisis and triage care for all Health Plan of Nevada and Behavioral Healthcare Options members in Southern Nevada and Northwestern Arizona."
The Company reported $4.1 million in cash as of December 31, 2006, compared to $1.8 million in June 30, 2006. The increase in the cash account was primarily due to $2.0 million in new equity financing that the company received at the end of the quarter. Consequently, the Company's balance sheet had a current ratio of 2:3 on December 31, 2006 and stockholders' equity increased 21.7 percent to $16.4 million as of December 31, 2006 from $13.5 million as of June 30, 2006.
Mr. Shear concluded, "We are pleased with the quarterly results, and look forward to a strong second half of the year. Despite certain necessary incremental expenses associated with the $80 million contract we closed with Behavioral Healthcare Options, we had healthy operating cash flow of $1.3 million, pre-tax income of $423,000, which is close to its historical high point in this seasonably slower quarter for us, and maintained profitability for the 24th consecutive quarter. Our balance sheet continues to strengthen as well, as evidenced by our higher cash position and ability to pay down our revolving credit line and term loan debt, which we reduced by $497,000 and $500,000, respectively. We have cause for optimism as we progress towards our long-term strategic goals."
Teleconference Information
The Company will host a conference call to discuss the fiscal 2007 second quarter results on Wednesday, February 14, 2007 at 9 a.m. Eastern Time. Interested parties within the United States can access the call by dialing 866-277-1184 and international callers may dial 617-597-5360. Please use passcode 47122216. A replay of the call also will be available until February 21, 2007 at 888-286-8010 for callers within the United States, and 617-801-6888 for international callers. Please use passcode 58872090 for the replay. This call is being webcast by CCBN, and can be accessed at PHC, Inc.'s web site at http://www.phc-inc.com/. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at http://www.fulldisclosure.com/, or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents, at http://www.streetevents.com/.
About Pioneer Behavioral Health
Pioneer Behavioral Health operates companies that provide inpatient and outpatient behavioral health care services, clinical research and Internet- and telephonic-based referral services. The companies contract with national insurance companies, government payors, and major transportation and gaming companies, among others, to provide such services. For more information, please visit http://www.phc-inc.com/ or http://www.haydenir.com/.
Statement under the Private Securities Litigation Reform Act of 1995:
Statement under the Private Securities Litigation Reform Act of 1995: This press release may include "forward-looking statements" that are subject to risks and uncertainties. Forward-looking statements include information about possible or assumed future results of the operations or the performance of the company and its future plans and objectives. Various future events or factors may cause the actual results to vary materially from those expressed in any forward-looking statements made in this press release. For a discussion of these factors and risks, see the company's annual report on Form 10-K for the most recently ended fiscal year.
Company Contact: Investor Relations Contact:
PHC, Inc. Hayden Communications, Inc.
Bruce A. Shear Matt Hayden or Peter Seltzberg
978-536-2777 843-272-4653
- tables follow -
PHC, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
December 31, June 30,
ASSETS 2006 2006
Current assets: (unaudited)
Cash and cash equivalents $4,150,210 $1,820,105
Accounts receivable, net of allowance
for doubtful accounts of $3,389,836
at December 31, 2006 and $3,100,586
at June 30, 2006 6,736,235 6,955,475
Pharmaceutical receivables 1,466,484 1,470,019
Prepaid expenses 863,292 490,655
Other receivables and advances 853,165 751,791
Deferred income tax asset 2,918,779 3,110,000
Total current assets 16,988,165 14,598,045
Accounts receivable, non-current 35,000 40,000
Other receivable 47,680 53,457
Property and equipment, net 2,018,990 1,799,888
Deferred financing costs, net of
amortization of $124,899 at
December 31, 2006 and $106,422
June 30, 2006 98,546 117,023
Customer relationships, net of
amortization of $320,000 at
December 31, 2006 and $260,000
at June 30, 2006 2,080,000 2,140,000
Goodwill 3,164,643 2,664,643
Other assets 828,190 571,931
Total assets $25,261,214 $21,984,987
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and short-term
notes payable $1,903,578 $1,518,615
Current maturities of long-term debt 1,120,998 909,057
Revolving credit note 1,105,949 1,603,368
Deferred revenue 388,967 385,742
Current portion of obligations under
capital leases 203,401 57,881
Accrued payroll, payroll taxes
and benefits 1,510,571 1,619,672
Accrued expenses and other liabilities 1,248,154 1,026,419
Total current liabilities 7,481,618 7,120,754
Long-term debt 1,006,783 1,021,546
Obligations under capital leases 74,619 61,912
Deferred tax liability 325,000 325,000
Total liabilities 8,888,020 8,529,212
Stockholders' equity:
Preferred Stock, 1,000,000 shares
authorized, none issued or outstanding -- --
Class A common stock, $.01 par value,
30,000,000 shares authorized,
19,175,592 and 17,874,966 shares issued
at December 31, 2006 and June 30, 2006,
respectively 191,756 178,749
Class B common stock, $.01 par value,
2,000,000 shares authorized, 775,760
issued and outstanding at
December 31, 2006 and June 30, 2006,
respectively, each convertible into one
share of Class A common Stock 7,758 7,758
Additional paid-in capital 26,078,238 23,718,197
Treasury stock, 199,098 shares of
Class A common stock at
December 31, 2006 and June 30, 2006,
at cost (191,700) (191,700)
Accumulated deficit (9,712,858) (10,257,229)
Total stockholders' equity 16,373,194 13,455,775
Total liabilities and stockholders'
equity $25,261,214 $21,984,987
PHC, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended Six Months Ended
December 31, December 31,
2006 2005 2006 2005
Revenues:
Patient
care, net $7,946,670 $6,465,356 $15,823,102 $13,178,336
Pharmaceutical
studies 873,920 1,084,084 1,925,303 2,390,093
Contract support
services 1,131,770 1,153,073 2,266,161 2,078,910
Total revenues 9,952,360 8,702,513 20,014,566 17,647,339
Operating expenses:
Patient care
expenses 4,243,531 3,292,393 8,199,183 6,554,304
Patient care
expenses,
pharmaceutical 421,549 510,834 908,486 1,073,988
Cost of contract
support services 687,174 587,067 1,525,729 1,184,862
Provision for
doubtful accounts 347,458 475,768 799,983 1,132,655
Administrative
expenses 3,118,099 2,749,100 6,213,554 5,378,776
Administrative
expenses,
pharmaceutical 529,555 538,291 1,208,663 1,172,290
Total operating
expenses 9,347,366 8,153,453 18,855,598 16,496,875
Income from
operations 604,994 549,060 1,158,968 1,150,464
Other income
(expense):
Interest income 33,808 15,397 66,657 38,261
Other income
(expense) (3,135) 21,263 (4,078) 32,048
Interest expense (212,441) (174,338) (332,271) (329,556)
Total other
expenses, net (181,768) (137,678) (269,692) (259,247)
Income before
provision for taxes 423,226 411,382 889,276 891,217
Provision for
income taxes 162,138 64,600 344,905 160,228
Net income $261,088 $346,782 $544,371 $730,989
Basic net income
per common share $0.01 $0.02 $0.03 $0.04
Basic weighted
average number
of shares
outstanding 18,758,151 18,159,188 18,636,146 18,125,265
Fully diluted
net income per
common share $0.01 $0.02 $0.03 $0.04
Fully diluted
weighted average
number of shares
outstanding 19,409,232 19,301,486 19,280,727 19,302,592
